- Home
- PAA vs BMRN Comparison
PAA vs BMRN Comparison
Compare PAA & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PAA | BMRN |
|---|---|---|
| Founded | 1981 | 1996 |
| Country | United States | United States |
| Employees | N/A | 3221 |
| Industry | Natural Gas Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.0B | 10.4B |
| IPO Year | N/A | 1999 |
Fundamental Metrics
Financial Performance| Metric | PAA | BMRN |
|---|---|---|
| Price | $22.45 | $54.14 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 18 |
| Target Price | $21.83 | ★ $88.22 |
| AVG Volume (30 Days) | ★ 2.8M | 1.4M |
| Earning Date | 05-08-2026 | 05-04-2026 |
| Dividend Yield | ★ 7.38% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.80 |
| Revenue | N/A | ★ $1,313,646,000.00 |
| Revenue This Year | $9.51 | $15.02 |
| Revenue Next Year | N/A | $12.23 |
| P/E Ratio | ★ $12.39 | $30.07 |
| Revenue Growth | N/A | ★ 17.62 |
| 52 Week Low | $15.69 | $50.76 |
| 52 Week High | $23.00 | $66.28 |
Technical Indicators
Market Signals| Indicator | PAA | BMRN |
|---|---|---|
| Relative Strength Index (RSI) | 58.18 | 44.95 |
| Support Level | $21.02 | $53.45 |
| Resistance Level | $22.79 | $56.21 |
| Average True Range (ATR) | 0.40 | 1.23 |
| MACD | 0.12 | 0.06 |
| Stochastic Oscillator | 70.07 | 47.29 |
Price Performance
Historical ComparisonAbout PAA Plains All American Pipeline L.P.
Plains All American Pipeline LP through its subsidiaries, engages in the pipeline transportation, terminaling, storage, and gathering of crude oil and natural gas liquids (NGL) in the United States and Canada. The company operates through two segments, Crude Oil and NGL. The Crude Oil segment offers gathering and transporting crude oil through pipelines, gathering systems, trucks, and barges or railcars. The NGL segment is involved in natural gas processing and NGL fractionation, storage, transportation, and terminalling. It generates the majority of its revenue from the Crude Oil segment.
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.